Importation of Exotic Species: Hearing Before the Committee on Environment and Public Works, United States Senate, One Hundred Eighth Congress, First Session, to Examine the Importation of Exotic Species and the Impact on Public Health and Safety, July 17, 2003

Front Cover
 

Other editions - View all

Common terms and phrases

Popular passages

Page 43 - FDA's blood-safety system includes the following five measures; all of which are relevant as we address the threat of West Nile virus: • Donor screening: Donors are provided educational materials and asked specific questions by trained personnel about their health and medical history. Potential donors whose blood may pose a health hazard are asked to exclude themselves. Donors also undergo medical screening to ensure that they are in good health at the time of donation. • Blood testing: After...
Page 90 - Administrator [Secretary], is authorized to make and enforce such regulations as in his judgment are necessary to prevent the introduction, transmission, or spread of communicable diseases from foreign countries into the States or possessions, or from one State or possession into any other State or possession
Page 16 - Thank you for your attention. I will be happy to answer any questions you may have.
Page 46 - It is unlawful for any person — (1) to import, export, transport, sell, receive, acquire, or purchase any fish or wildlife or plant taken, possessed, transported, or sold in violation of any law, treaty, or regulation of the United States or in violation of any Indian tribal law...
Page 61 - ... catastrophic storm of microbial threats.** Dramatic advances in science, technology, and medicine have enabled us to make great strides forward in our struggle to prevent and control infectious diseases, yet we cannot fall prey to an illusory complacency. We must understand that pathogens — old and new — are endlessly resourceful in adapting to and breaching our defenses.
Page 43 - Quarantine: Donated blood must be quarantined until it is thoroughly tested and the donation records have been verified. Problems and deficiencies: Blood establishments must investigate any failures of these safeguards, and correct system deficiencies that are found by the firms or through FDA inspection. Firms must report to FDA any manufacturing problems, eg biological product deviations that may affect the safety, purity, or potency of their products.
Page 40 - Health (NIH), the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the Agency for Toxic Substances and Disease Registry (among other agencies).
Page 10 - Thank you again for the opportunity to speak with you today. I will be glad to respond to specific questions on these important issues.
Page 57 - Thirteen individual factors — some reflecting the ways of nature, most of them reflecting our ways of life — account for new or enhanced microbial tbreats.
Page 34 - For every complex problem, there is a solution that is simple, neat and wrong.

Bibliographic information